Target species
Dogs, cats and horses.
Indications for use
Treatment of keratitis, conjunctivitis and blepharitis caused by Staphylococcus spp., Streptococcus spp., Proteus spp. and/or Pseudomonas spp.
Contraindications
Do not use in cases of hypersensitivity to the active substance, to other tetracyclines or to any of the excipients.
Special precautions for use in animals
Use of the veterinary medicinal product should be based on identification and susceptibility testing of the target pathogen(s). If this is not possible, therapy should be based on epidemiological information and knowledge of susceptibility of the target pathogens at farm level, or at local/regional level.
Use of the product should be in accordance with official, national and regional antimicrobial policies.
Use of the veterinary medicinal product deviating from the instructions given in this datasheet may increase the prevalence of bacteria resistant to chlortetracycline and may decrease the effectiveness of treatment with other tetracyclines due to the potential for cross-resistance.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
This veterinary medicinal product may cause skin sensitisation, hypersensitivity reactions and/or eye irritation.
People with a known hypersensitivity to tetracyclines should avoid contact with the veterinary medicinal product.
Avoid contact with the skin and eyes.
Personal protective equipment consisting of impermeable gloves should be worn when handling the product.
In case of contact with the skin, wash exposed skin with water and soap. If you develop symptoms following exposure such as a skin rash, seek medical advice immediately and show the package leaflet or label to the physician.
In case of contact with the eyes, wash immediately with clean water. If irritation persists, seek medical advice immediately and show the package leaflet or label to the physician.
Wash hands after use.
Special precaution for the protection of the environment.
Not applicable.
Adverse reactions
Dog, Cat, Horse:
Very rare (<1 animal/10, 000 animals treated, including isolated reports): | Application site reaction Eye disorder (e.g. Eye irritation, Eye itching, Swollen eye, Eye redness) |
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Use during pregnancy and lactation and lay
The safety of the veterinary medicinal product has not been established during pregnancy and lactation.
Pregnancy and lactation:
Use only according to the benefit/risk assessment by the responsible veterinarian.
Interactions with other medicinal products and other forms of interaction
No data available.
Amounts to be administered and administration route
For ocular use only.
Horses: Apply 2-3 cm of ointment (depending on the size of the animal) in the conjunctival sac 4 times a day for 5 days. If after 3 days of treatment no clinical improvement has occurred, alternative therapy should be considered.
Dogs and cats: Apply 0.5-2 cm of ointment (depending on the size of the animal) in the conjunctival sac 4 times a day for 5 days. If after 3 days of treatment no clinical improvement has occurred, alternative therapy should be considered.
Withdrawal periods
Meat and offal: 1 day
Not authorised for use in horses producing milk intended for human consumption.